MX2012002477A - Derivados de oxindol alqueno y sus usos para tratar obesidad, diabetes e hiperlipidemia. - Google Patents

Derivados de oxindol alqueno y sus usos para tratar obesidad, diabetes e hiperlipidemia.

Info

Publication number
MX2012002477A
MX2012002477A MX2012002477A MX2012002477A MX2012002477A MX 2012002477 A MX2012002477 A MX 2012002477A MX 2012002477 A MX2012002477 A MX 2012002477A MX 2012002477 A MX2012002477 A MX 2012002477A MX 2012002477 A MX2012002477 A MX 2012002477A
Authority
MX
Mexico
Prior art keywords
hyperlipidemia
alkene
diabetes
treat obesity
oxindole derivatives
Prior art date
Application number
MX2012002477A
Other languages
English (en)
Inventor
Li Chen
Fajun Nan
Lichun Feng
Mengwei Huang
Jia Li
Tao Pang
Lifang Yu
Mei Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2012002477A publication Critical patent/MX2012002477A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

Un compuesto de la fórmula (I) así como una sal farmacéuticamente aceptable del mismo, en donde R1 a R7 tiene el significado dado en la reivindicación 1, puede ser utilizado como medicamento.
MX2012002477A 2009-09-21 2010-09-20 Derivados de oxindol alqueno y sus usos para tratar obesidad, diabetes e hiperlipidemia. MX2012002477A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2009/074060 WO2011032320A1 (en) 2009-09-21 2009-09-21 Novel alkene oxindole derivatives
PCT/EP2010/063770 WO2011033099A1 (en) 2009-09-21 2010-09-20 Alkene oxindole derivatives and their uses to treat obesity, diabetes and hyperlipidemia

Publications (1)

Publication Number Publication Date
MX2012002477A true MX2012002477A (es) 2012-03-26

Family

ID=43414813

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012002477A MX2012002477A (es) 2009-09-21 2010-09-20 Derivados de oxindol alqueno y sus usos para tratar obesidad, diabetes e hiperlipidemia.

Country Status (10)

Country Link
US (3) US20110071195A1 (es)
EP (1) EP2480530A1 (es)
JP (1) JP2013505281A (es)
KR (1) KR20120068876A (es)
AU (1) AU2010297252A1 (es)
BR (1) BR112012006172A2 (es)
CA (1) CA2772674A1 (es)
IN (1) IN2012DN00765A (es)
MX (1) MX2012002477A (es)
WO (2) WO2011032320A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011032320A1 (en) * 2009-09-21 2011-03-24 F. Hoffmann-La Roche Ag Novel alkene oxindole derivatives
WO2013119774A1 (en) * 2012-02-10 2013-08-15 Virginia Commonwealth University 3-(2-amino-ethyl)-alkylidene)-thiazolidine-2,4-dione and 1-(2-amino-ethyl)-alkylidene-1,3-dihydro-indol-2-one derivatives as selective sphingosine kinase 2 inhibitors
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
EP2769974A1 (en) * 2013-02-21 2014-08-27 Debiopharm S.A. Novel AMPK activator
JP6064062B2 (ja) 2013-03-15 2017-01-18 ファイザー・インク Ａｍｐｋを活性化させるインダゾール化合物
EP3010903A1 (en) * 2013-06-20 2016-04-27 Boehringer Ingelheim International GmbH Olefin substituted oxindoles having ampk activity
EP2886541A1 (en) * 2013-12-19 2015-06-24 Sanofi Oxindole derivatives, preparation thereof and therapeutic use in the treatment of AMPK-related diseases
ES2567105B1 (es) * 2014-09-19 2017-02-10 Consejo Superior De Investigaciones Científicas (Csic) Derivados de indol para la prevención y/o tratamiento de diabetes ytrastornos metabólicos relacionados
CN106619616A (zh) * 2015-11-04 2017-05-10 中国科学院上海药物研究所 3-烯基吲哚酮类衍生物在制备治疗miri药物中的用途及其药物组合物
CA3178994A1 (en) 2020-05-19 2021-11-25 Iyassu Sebhat Ampk activators
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE243034T1 (de) * 1996-01-17 2003-07-15 Taiho Pharmaceutical Co Ltd Intimale verdickungsinhibitoren
ES2239393T3 (es) * 1997-05-07 2005-09-16 Sugen, Inc. Derivados de 2-indolinona utilizados como moduladores de la actividad de la proteina-quinasa.
DE19816624A1 (de) * 1998-04-15 1999-10-21 Boehringer Ingelheim Pharma Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
TW200745033A (en) * 2005-09-14 2007-12-16 Dainippon Sumitomo Pharma Co Oxindole derivative as feeding control agent
CN101553482B (zh) * 2006-09-15 2013-11-20 艾科睿制药公司 激酶抑制剂化合物
WO2009076631A1 (en) * 2007-12-12 2009-06-18 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
US8273744B2 (en) * 2008-02-04 2012-09-25 Mercury Therapeutics, Inc. AMPK modulators
WO2010051206A1 (en) * 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
WO2011032320A1 (en) * 2009-09-21 2011-03-24 F. Hoffmann-La Roche Ag Novel alkene oxindole derivatives

Also Published As

Publication number Publication date
US20110071195A1 (en) 2011-03-24
IN2012DN00765A (es) 2015-06-26
US20140288127A1 (en) 2014-09-25
BR112012006172A2 (pt) 2016-05-31
CA2772674A1 (en) 2011-03-24
AU2010297252A1 (en) 2012-02-02
US20130131114A1 (en) 2013-05-23
EP2480530A1 (en) 2012-08-01
WO2011033099A1 (en) 2011-03-24
WO2011032320A1 (en) 2011-03-24
JP2013505281A (ja) 2013-02-14
US8778973B2 (en) 2014-07-15
KR20120068876A (ko) 2012-06-27

Similar Documents

Publication Publication Date Title
MX2012002477A (es) Derivados de oxindol alqueno y sus usos para tratar obesidad, diabetes e hiperlipidemia.
HK1158192A1 (en) Piperidine gpcr agonists
MX2009007180A (es) Agonistas del receptor acoplado a la proteina g de la piperidina.
HK1149258A1 (en) Compounds
AU2011274192A8 (en) Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
GB0812642D0 (en) Compounds
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
MY153985A (en) Aminotriazole derivatives as alx agonists
MX2011012017A (es) Nuevos derivados azaciclicos como inhibidores de lipasa sensible a las hormonas (hsl).
IN2012DN03182A (es)
UA107649C2 (uk) Ізоксазол-ліганди метаботропного рецептора глутамату та їх застосування як потенціаторів
MX2011011733A (es) Inhiibidores de dihidroorotato deshidrogenasa como compuestos virostaticos.
MX2012006233A (es) Nuevos compuestos de espiropiperidina.
IN2012DN03337A (es)
MX342440B (es) Derivados fluorados de aminotriazol.
UA109037C2 (uk) Триазолопіридини
MY165918A (en) Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
MX2013002329A (es) Agonista de receptores de neutrofina y sus usos como medicamentos.
IN2012DN03042A (es)
IN2012DN01232A (es)
UA104422C2 (uk) Похідні індолу та їх застосування для профілактики або лікування діабету або ожиріння
EA201000439A1 (ru) Бензотиазолы в качестве модуляторов рецептора грелина
MX2010006108A (es) Inhibidores de estearoil-coa-desaturasa.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal